Nivolumab After Induction Treatment in Triple-negative Breast Cancer (TNBC) Patients
Clinical trial NCT02499367 · UNKNOWN
Trial details
- NCT number
- NCT02499367
- Sponsor
- The Netherlands Cancer Institute
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-08-01
- Primary completion
- 2023-12-01
- Enrollment
- 84
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.